Applied pharmacoeconomics: evaluation and use of pharmacoeconomic data from the literature

ASHP Guidelines on the Pharmacy and Therapeutics Committee and the Formulary System

“…Institution-specific costs are often different from the costs used in published studies, and local data should be used when incorporating their results into medication reviews. 37,38 Even if a formal pharmacoeconomic evaluation is not included in a drug review document, a financial evaluation must be conducted, including consideration of nonmedication-related costs and financial consequences to the pharmacy and to the organization as a whole.…”

An update on the pharmacoeconomics of antifungal pharmacotherapy

“…A well-designed study may be utilized to support decisions within a health care system, such as to guide individualized patient treatment options, direct formulary management, and develop preferred drug-use guidelines and disease-state treatment algorithms [55]. Due to the variances between each type of study, providers should ensure that it meets adequate criteria, especially when considering the application or generalization to all health care systems or specifi c patient populations.…”

Comparison of Two Management Strategies for Helicobacter pylori Treatment: Clinical Study and Cost‐effectiveness Analysis

“…Probabilities of cure rates and other events were modified in the range of plausible variations; baseline health-care costs were also modified, to test the stability of the baseline conclusions in different possible settings and backgrounds [16]. Third, the total cost of each alternative was computed as the overall sum of its branch costs to obtain the baseline results of the analysis.…”